US Dollar vs MXN

Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

Regístrate

PSTX Poseida Therapeutics Inc

3.34

-0.12 (-3.47%)

16 May 2024 - Cerrado

Retrasado por 15 minutos

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Poseida Therapeutics (NASDAQ:PSTX)
Gráfica de Acción Histórica
De Abr 2024 a May 2024

Haga Click aquí para más Gráficas Poseida Therapeutics.

Poseida Therapeutics (NASDAQ:PSTX)
Gráfica de Acción Histórica
De May 2023 a May 2024

Haga Click aquí para más Gráficas Poseida Therapeutics.

Noticias sobre Poseida Therapeutics Inc PSTX

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Martes 14 de Mayo 2024 (2 días hace) • Edgar (US Regulatory)

Form 8-K - Current report
Martes 14 de Mayo 2024 (2 días hace) • Edgar (US Regulatory)

Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2024
Martes 14 de Mayo 2024 (2 días hace) • PR Newswire (US)

Poseida Highlights Strong Progress on Its Genetic Medicine Programs at the American Society for Gene and Cell Therapy 27th Annual Meeting
Jueves 9 de Mayo 2024 (1 semana hace) • PR Newswire (US)

Form EFFECT - Notice of Effectiveness
Domingo 5 de Mayo 2024 (2 semanas hace) • Edgar (US Regulatory)

Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology
Miércoles 1 de Mayo 2024 (2 semanas hace) • PR Newswire (US)

Biotech Soars on Research Collaboration And License Agreement Release
Miércoles 1 de Mayo 2024 (2 semanas hace) • AllPennyStocks.com

Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology
Miércoles 1 de Mayo 2024 (2 semanas hace) • PR Newswire (US)

Poseida Therapeutics Announces Strong Lineup of Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
Jueves 18 de Abril 2024 (4 semanas hace) • PR Newswire (US)

Poseida Therapeutics Hosts Gene Therapy R&D Day Highlighting New Scientific Advancements and Pipeline Focus
Miércoles 17 de Abril 2024 (4 semanas hace) • PR Newswire (US)

Poseida Therapeutics Presents New Phase 1 Data at AACR 2024 Supporting Potential of P-BCMA-ALLO1 Allogeneic CAR-T Therapy to Benefit Broad Range of Patients with Multiple Myeloma
Lunes 8 de Abril 2024 (1 mes hace) • PR Newswire (US)

Poseida Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Lunes 1 de Abril 2024 (1 mes hace) • PR Newswire (US)

Más de Poseida Therapeutics Inc Artículos de Noticias

Vistas Media Acquisition

Treasury Metals

Emmaus Life Sciences

Bank of Montreal Autocal...

Adit EdTech Acquisition

Vontobel Financial Produ...

Nestle Nam Sf 1 Adr

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones